In the largest analysis of its kind, researchers at the Duke Cancer Institute and other top cancer centers have found that the organ site where prostate cancer spreads has a direct impact on survival.
Read MoreA new study from suggests that statins either alone or in combination with metformin may reduce the risk of dying from prostate cancer. The study’s findings were presented at the American Society of Clinical Oncology annual meeting in Chicago. The study was carried out by Grace L. Lu-Yao, PhD, an epidemiologist at the Rutgers Cancer Institute of New Jersey in New Brunswick.
Read MoreJohnathan Watkins of King's College London published the first ever study analyzing the health effects of unemployment related to prostate cancer in the journal, eCancerMedicalScience — an open access journal from the European Institute of Oncology.
Read More
